QA Benzalkonium Chloride is also known as BZK, BKC, BAK, alkyl dimethyl benzyl ammonium chloride and ADBAC. Our FeF Benzalkonium Chloride products have proven efficacy against a broad spectrum of microorganisms (gram + and – & acid fast bacteria, yeast, moulds, enveloped viruses). They are effective through a wide pH range, are surface active/adhesive cationic agents and do not add unpleasant odour/colour to finished formulations. Benzyl (dodecyl) dimethyl ammonium chloride (approx. 65%), Benzyl (tetradecyl) dimethyl ammonium chloride (approx. 35%). Approx. 50% active ingredients

QA CTAB or Cetrimonium bromide can be used for several purposes in the pharma industry. As a pharmaceutical ingredient, it is an antiseptic agent with various antibacterial, antifungal and other antimicrobial properties. It is used in various products such as throat lozenges and antiseptic topical gels and creams for a range of purposes. As a processing aid or auxiliary, it can be used in the downstream vaccine manufacturing process, typically for both bacterial polysaccharide vaccines and viral vaccines (e.g. influenza)..

Benzalkonium Chloride is also known as BZK, BKC, BAK, alkyl dimethyl benzyl ammonium chloride and ADBAC. Our FeF Benzalkonium Chloride products have proven efficacy against a broad spectrum of microorganisms (gram + and – & acid fast bacteria, yeast, moulds, enveloped viruses). They are effective through a wide pH range, are surface active/adhesive cationic agents and do not add unpleasant odour/colour to finished formulations. Benzyl (dodecyl) dimethyl ammonium chloride (approx. 45%), Benzyl (tetradecyl) dimethyl ammonium chloride (approx. 55%). Approx. 50% active ingredients

Sheffied Tabletting System Disintequik MCC 25 is a co-processed excipient consisting of 75% Alpha monohydrate lactose and 25% Microcrystalline Cellulose (MCC). The processing results in a co-agglomeration compound of the two ingredients, spray dried lactose and MCC, preserving the identity of each component. Prior to processing, both ingredients meet all of the requirements as outlined in the current monographs of the EU, JP and NF. Disintequick MCC 25 reduces raw materials QC Testing, Manufacturing Steps and process validation. A Drug Master File is available. Added benefits include: reduction of blending issues, low dust generation, the avoidance of costly wet granulation processes, improved flowability and content uniformity during compression.